Mail

Mail Earmark Science The practice of funding science with congressional earmarks1 is just the tip of the iceberg. I fear that we are experiencing a general disintegration of the quality and integrity of American science and engineering. From fundamental research to operating decisions like the ones made on the Deepwater Horizon that led to the disaster in the Gulf, bad technical decisions are being made—more often than not driven by politicians, lawye

Written byThe Scientist
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The practice of funding science with congressional earmarks1 is just the tip of the iceberg. I fear that we are experiencing a general disintegration of the quality and integrity of American science and engineering. From fundamental research to operating decisions like the ones made on the Deepwater Horizon that led to the disaster in the Gulf, bad technical decisions are being made—more often than not driven by politicians, lawyers, managers, and accountants with little or no relevant technical knowledge.

The Department of Defense and the Department of Energy have effectively turned most of their scientists and engineers into contract monitors. Privatization of research has turned many of our academic researchers into prostitutes, willing to lie, cheat, and blow in the ear of anyone with money. We need to begin to demand better of our leaders and ourselves. If we do not, we can look forward to more pork in research, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies